Search
En un ensayo clínico de MSK se descubrió que participar en clases de terapia integral en línea podría beneficiar a los pacientes que padecen cáncer y reciben tratamiento activo, no solo porque reduce la fatiga, la ansiedad y la depresión, sino también porque disminuye las tasas de hospitalización.
A gift from the estate of renowned fashion designer Geoffrey Beene will enable MSKCC to launch an ambitious research initiative to be known as the Geoffrey Beene Cancer Research Center.
Learn how MSK is Improving patients’ quality of life with less toxic treatments.
A new tool called optogenetics is revealing clues about the function of a promising experimental therapy derived from stem cells.
Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.
MSK has been named one of the top employers in the country, according to Forbes magazine’s 2022 list of America’s Best Large Employers. MSK placed at no. 4 out of 500 employers with more than 5,000 employees.
Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.
This photo essay showcases the critical role trainees play within MSK's research enterprise.
People with bladder cancer may soon have a new treatment option following surgery.
Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.